Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For ECR.MC
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Bad
0%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q3 Q4 Δ in %
Current Ratio 36.37 1.74 1.28
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 94.70 15.71 -8.07
Naive Interpretation member
2 Per Share
Metric Q3 Q4 Δ in %
Book Value 0.84 4.00 3.97
Cash 189.09 -1.24 0.43
Capex n.A. n.A. -0.17
Free Cash Flow n.A. n.A. 0.22
Revenue -38.45 2.00 3.24
Naive Interpretation member
3 Profitability
Metric Q3 Q4 Δ in %
Gross Margin 341.34 0.35 0.08
Operating Margin -61.47 0.04 -0.09
ROA -69.29 < 0.005 0.02
ROE -72.61 < 0.005 0.03
ROIC -62.43 0.01 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of ECR.MC is permitted for members.
5 Growth
The "Growth Entry" for the Focus of ECR.MC is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of ECR.MC is permitted for members.